Combinatorial microRNA target predictions A Krek, D Grün, MN Poy, R Wolf, L Rosenberg, EJ Epstein, ... Nature genetics 37 (5), 495-500, 2005 | 5640 | 2005 |
A human snoRNA with microRNA-like functions C Ender, A Krek, MR Friedländer, M Beitzinger, L Weinmann, W Chen, ... Molecular cell 32 (4), 519-528, 2008 | 991 | 2008 |
Comprehensive evaluation of differential gene expression analysis methods for RNA-seq data F Rapaport, R Khanin, Y Liang, M Pirun, A Krek, P Zumbo, CE Mason, ... Genome biology 14, 1-13, 2013 | 886 | 2013 |
Cell-type-specific signatures of microRNAs on target mRNA expression P Sood, A Krek, M Zavolan, G Macino, N Rajewsky Proceedings of the National Academy of Sciences 103 (8), 2746-2751, 2006 | 792 | 2006 |
Dicer ablation affects antibody diversity and cell survival in the B lymphocyte lineage SB Koralov, SA Muljo, GR Galler, A Krek, T Chakraborty, C Kanellopoulou, ... Cell 132 (5), 860-874, 2008 | 715 | 2008 |
A genome-wide map of conserved microRNA targets in C. elegans S Lall, D Grün, A Krek, K Chen, YL Wang, CN Dewey, P Sood, T Colombo, ... Current biology 16 (5), 460-471, 2006 | 560 | 2006 |
Integrated proteogenomic characterization of clear cell renal cell carcinoma DJ Clark, SM Dhanasekaran, F Petralia, J Pan, X Song, Y Hu, ... Cell 179 (4), 964-983. e31, 2019 | 489 | 2019 |
Proteogenomic characterization reveals therapeutic vulnerabilities in lung adenocarcinoma MA Gillette, S Satpathy, S Cao, SM Dhanasekaran, SV Vasaikar, K Krug, ... Cell 182 (1), 200-225. e35, 2020 | 460 | 2020 |
Proteogenomic and metabolomic characterization of human glioblastoma LB Wang, A Karpova, MA Gritsenko, JE Kyle, S Cao, Y Li, D Rykunov, ... Cancer cell 39 (4), 509-528. e20, 2021 | 390 | 2021 |
Proteogenomic characterization of endometrial carcinoma Y Dou, EA Kawaler, DC Zhou, MA Gritsenko, C Huang, L Blumenberg, ... Cell 180 (4), 729-748. e26, 2020 | 325 | 2020 |
Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma C Huang, L Chen, SR Savage, RV Eguez, Y Dou, Y Li, ... Cancer cell 39 (3), 361-379. e16, 2021 | 219 | 2021 |
Integrated proteogenomic characterization across major histological types of pediatric brain cancer F Petralia, N Tignor, B Reva, M Koptyra, S Chowdhury, D Rykunov, A Krek, ... Cell 183 (7), 1962-1985. e31, 2020 | 206 | 2020 |
A proteogenomic portrait of lung squamous cell carcinoma S Satpathy, K Krug, PMJ Beltran, SR Savage, F Petralia, C Kumar-Sinha, ... Cell 184 (16), 4348-4371. e40, 2021 | 190 | 2021 |
Guidelines for bioinformatics of single-cell sequencing data analysis in Alzheimer’s disease: review, recommendation, implementation and application M Wang, W Song, C Ming, Q Wang, X Zhou, P Xu, A Krek, Y Yoon, L Ho, ... Molecular neurodegeneration 17 (1), 17, 2022 | 47 | 2022 |
microRNAs regulate cell-to-cell variability of endogenous target gene expression in developing mouse thymocytes R Blevins, L Bruno, T Carroll, J Elliott, A Marcais, C Loh, A Hertweck, ... PLoS genetics 11 (2), e1005020, 2015 | 32 | 2015 |
Genome-wide mapping of the distribution of CarD, RNAP σA, and RNAP β on the Mycobacterium smegmatis chromosome using chromatin immunoprecipitation sequencing R Landick, A Krek, MS Glickman, ND Socci, CL Stallings Genomics data 2, 110-113, 2014 | 18 | 2014 |
Proteogenomic analysis of chemo-refractory high-grade serous ovarian cancer S Chowdhury, JJ Kennedy, RG Ivey, OD Murillo, N Hosseini, X Song, ... Cell 186 (16), 3476-3498. e35, 2023 | 8 | 2023 |
BayesDeBulk: a flexible bayesian algorithm for the deconvolution of bulk tumor data F Petralia, A Krek, AP Calinawan, S Feng, S Gosline, P Pugliese, ... bioRxiv, 2021.06. 25.449763, 2021 | 7 | 2021 |
Gut-associated lymphoid tissue attrition associates with response to anti-α4β7 therapy in ulcerative colitis P Canales-Herrerias, M Uzzan, A Seki, RS Czepielewski, B Verstockt, ... Science Immunology 9 (94), eadg7549, 2024 | 5 | 2024 |
Pan-cancer proteogenomics characterization of tumor immunity F Petralia, W Ma, TM Yaron, FP Caruso, N Tignor, JM Wang, ... Cell, 2024 | 5 | 2024 |